Overview

Vitamin D and Residual Beta-Cell Function in Type 1 Diabetes

Status:
Active, not recruiting
Trial end date:
2021-08-31
Target enrollment:
Participant gender:
Summary
This project is designed to study the role of vitamin D supplementation on the honeymoon phase of type 1 diabetes in children who are on standardized insulin treatment. The results could lead to significant changes in the approach to the early phase of type 1 diabetes with a strong emphasis on prolonging the honeymoon phase by using vitamin D and maintaining these patients on a standardized insulin regimen. The overall goal is to reduce the long-term complications of type 1 diabetes.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Benjamin U. Nwosu, MD
University of Massachusetts, Worcester
Collaborators:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
University of Massachusetts, Worcester
Treatments:
Ergocalciferols
Vitamin D
Vitamins